Paperpal Prime Logo

Bleeding, Thrombosis and Vascular Biology : Impact Factor & More

eISSN: 2785-5309
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Bleeding, Thrombosis and Vascular Biology Journal Specifications

Indexed in the following public directories

  • DOAJ DOAJ
Overview
Publisher PAGEPress Publications
Language English
Publication Time14
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorSISET Società Italiana per lo Studio dell'Emostasi e Trombosi
Website URLVisit website
Publication Details
Publication Time 14
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Bleeding, Thrombosis and Vascular Biology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Bleeding, Thrombosis and Vascular Biology

Anticoagulation in advanced renal failure: do factor XI/XIa inhibitors represent the long-awaited shift?
  • 23 Oct 2026
  • Bleeding, Thrombosis and Vascular Biology
Inherited platelet function disorders: a comprehensive narrative review focusing on diagnostic and management aspects
  • 21 Oct 2026
  • Bleeding, Thrombosis and Vascular Biology
Antithrombotic therapy in retinal vein occlusion: many questions, few evidence-based answers
  • 19 Oct 2026
  • Bleeding, Thrombosis and Vascular Biology
When is percutaneous left atrial appendage closure a valid alternative to oral anticoagulation in atrial fibrillation?
  • 16 Oct 2026
  • Bleeding, Thrombosis and Vascular Biology
Executive summary of the consensus-based guidance from the SISET (Italian Society for the Study of Hemostasis and Thrombosis) for the management of inferior vena cava thrombosis
  • 16 Oct 2026
  • Bleeding, Thrombosis and Vascular Biology
CO-82 | ACQUIRED SEVERE FACTOR XIII DEFICIENCY AS THE INITIAL PRESENTATION OF PAEDIATRIC ACUTE PROMYELOCYTIC LEUKAEMIA
  • 14 Oct 2026
  • Bleeding, Thrombosis and Vascular Biology
Anticoagulation in advanced renal failure: do factor XI/XIa inhibitors represent the long-awaited shift?
  • 23 Oct 2026
  • Bleeding, Thrombosis and Vascular Biology
Inherited platelet function disorders: a comprehensive narrative review focusing on diagnostic and management aspects
  • 21 Oct 2026
  • Bleeding, Thrombosis and Vascular Biology
Antithrombotic therapy in retinal vein occlusion: many questions, few evidence-based answers
  • 19 Oct 2026
  • Bleeding, Thrombosis and Vascular Biology
When is percutaneous left atrial appendage closure a valid alternative to oral anticoagulation in atrial fibrillation?
  • 16 Oct 2026
  • Bleeding, Thrombosis and Vascular Biology
Executive summary of the consensus-based guidance from the SISET (Italian Society for the Study of Hemostasis and Thrombosis) for the management of inferior vena cava thrombosis
  • 16 Oct 2026
  • Bleeding, Thrombosis and Vascular Biology
CO-82 | ACQUIRED SEVERE FACTOR XIII DEFICIENCY AS THE INITIAL PRESENTATION OF PAEDIATRIC ACUTE PROMYELOCYTIC LEUKAEMIA
  • 14 Oct 2026
  • Bleeding, Thrombosis and Vascular Biology

FAQs on Bleeding, Thrombosis and Vascular Biology